Genmab A/S (Nasdaq: GMAB) today announced new and updated data from three arms of the ongoing Phase 1b/2 EPCORE® CLL-1 trial (NCT04623541) evaluating the efficacy and safety of epcoritamab-bysp, a ...
Information Services Group ( ISG) (Nasdaq: III ), a global AI-centered technology research and advisory firm, has launched a research study examining IT service providers and contract research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback